检索到与临床功效和安全性相关的两个随机对照试验(rct)、一个前后对照研究、两个回顾性报告，以及18个药物动力学研究。
Two randomized controlled trials (RCTs), one before-and-after study and two retrospective reports on clinical efficacy and safety were retrieved, together with 18 pharmacokinetic studies.
巴格列酮已经经过一系列临床前期药效药理学、安全药理学、药代动力学或毒性动力学和药物代谢研究的评估。
Balaglitazone has been evaluated in a series of preclinical efficacy pharmacology, safety pharmacology, pharmacokinetic/toxicokinetic, and drug metabolism studies.
获取有关酶动力学参数的细节对于药物开发和临床诊断都是至关重要的。
Acquiring details about the kinetic parameters of enzymes is crucial to both drug development and clinical diagnosis.
应用推荐